AP301
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for AP301, covering 2019-11-18 to 2026-01-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China [Phase 3]